RxDoctor Payments Data

Shannon Jakubas, PA

Physician Assistant · Richland, MINPI 1518648609

Payments from drug & device makers

$1,186in general payments, 2019–2025

Across 44 payments — averaging $26.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$303
  • Novo Nordisk$248
  • Abbott$154
  • Pfizer$106
  • AbbVie$84
  • Amgen$55
  • plus $238 from 9 others

What the payments were for

  • Food & beverage$1,186100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,186 in reported general payments places this provider in the 75th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Medicare billing

Part B allowed, 2024
$26,444
Medicare patients
128
Services billed
374

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin52$56,736
EliquisApixaban35$35,673
MounjaroTirzepatide23$29,195
OzempicSemaglutide24$28,409
FarxigaDapagliflozin Propanediol26$20,112
Breo ElliptaFluticasone/Vilanterol11$4,063
Atorvastatin Calcium247$3,693
SymbicortBudesonide/Formoterol Fumarate13$3,588
Colestipol Hcl17$3,450
Metoprolol Succinate87$1,928
Omeprazole128$1,893
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen105$1,703
Levothyroxine Sodium140$1,616
Tamsulosin Hcl67$1,582
Albuterol Sulfate HfaAlbuterol Sulfate46$1,578

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$24$56,73652 claims
PfizerEliquis$106$35,67335 claims
Lilly USA, LLCMounjaro$36$29,19523 claims
Novo NordiskOzempic$248$28,40924 claims
AstraZenecaFarxiga, Symbicort$303$23,70039 claims
AbbVieArmour Thyroid$84$94913 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Richland

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →